OverviewSuggest Edit

    Senzime is a company that develops monitoring systems to assess patients'​ biochemical and physiological processes before, during, and after surgery. It provides bedside solutions that enable automated and continuous monitoring of life-critical substances such as glucose and lactate in both blood and tissues. The company also develops TetraGraph, a digital system for monitoring patients undergoing anesthesia with neuromuscular blocking agents (NMBAs).

    Senzime Online and Social Media Presence

    Embed Graph

    Senzime Frequently Asked Questions

    • When was Senzime founded?

      Senzime was founded in 1999.

    • Who are Senzime competitors?

      Competitors of Senzime include ImmunoScience, Exalenz Bioscience and Biomed Diagnostics.